Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT03066089

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Chemical Resources (from the registry)
Registry
  • NCT NCT03066089
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03066089. Non-randomized; no masking; primary purpose supportive care. Start 2015-12-14 (actual); primary completion 2017-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Fenfuro
Lead sponsor
Chemical Resources (class: industry)

Record details

Record id
cardio:ct-nct03066089
Content hash
de03c7d34dbff1ccf9c22643f8f0f38e0c69d0003095ded4382c9f095470546d